Jay Hetzel PhD, FTSE, FAICD


Dr Hetzel has a background in life sciences research, product development and commercialisation.  He had a distinguished research career with CSIRO for more than 20 years in animal genetics and genomics. In 1998 he co-founded Genetic Solutions to commercialise genomics technology in livestock. The company was sold to Pfizer Animal Health in 2008. He has since worked on commercialising a range of bio-based products in early-stage ventures and was the past Chairman of ASX-listed Anatara Lifesciences Ltd and Leaf Resources Ltd. He is a Fellow of the Australian Academy of Technology and Engineering and a Fellow of the Australian Institute of Company Directors. 



John Grant MIEAust, MAICD


Mr Grant has a background in civil engineering, information technology and sports administration.  He graduated from the University of Queensland with honours in Civil Engineering and spent 10 years with the Brisbane City Council in civil design, construction and quarry management.  Computerisation of the BCC’s quarrying operations led him into sales with IBM, before joining and subsequently becoming a partner of what ultimately became ASX-listed Data#3 Limited.  As CEO/Managing Director, he led the business from its listing in 1997 to one with more than 1000 staff and revenues approaching $1 billion. Over 25 years, Mr Grant actively developed Australia’s IT industry, Chairing the Australian Information Industry Association (AIIA), the Australian Government’s IT Industry Innovation Council and the Queensland Government’s IT Industry Advisory Board.  He also served on the Queensland Government’s Smart State Council. In 2008 he was inducted into the Australian IT industry’s Hall of Fame, and in 2010 was awarded the industry’s top accolade, the Pearcey Medal for distinguished lifetime achievement and contribution to the information and communications technology industry.  He played rugby league at the club, state and national levels representing Australia in the 1972 World Cup.  In 2012 he was appointed the inaugural Chairman of the Australian Rugby League Commission, overseeing significant change in the game both on and off-field, before stepping down in 2018. 


Richard Moore BSc (Hons) 


Mr Moore is an early-stage technology company mentor and capital-raising advisor.  For nine years he was CEO of Brisbane-based ASX-listed global internet company Dark Blue Sea, which specialised in domain names and internet advertising. Previously, Mr Moore had an extensive career in the financial services industry: working for Bankers Trust Australia’s funds management business trading Australian equities and derivatives and undertaking quantitative, macro and equities research, and as a member of the asset allocation group. At Citigroup he established its equity capital markets business in Australia and worked on more than 30 successful transactions. Mr Moore holds a First-Class Honours Degree in Pure Mathematics with majors in Applied Mathematics and Computer Science.



Linda Ginger  


Ms Ginger has 20+ years’ strategic marketing experience spanning three continents for a multitude of industries and companies; multinational corporates, SME and NFP’s.  Her specialisms include market positioning, brand strategy, go-to-market, marketing strategy and communications planning.

Until recently Ms Ginger was CEO of U.S. based data science research firm, Growth Science, which manages and operates MESE™, an actuarial based computing system founded on research started at Intel and Harvard Business School in 2006 and today guides growth and innovation investment decisions for its Fortune500 member base. 

Ms Ginger remains a board member of Growth Science, shares the ongoing research of MESE™ via speaking engagements, and helps small to medium companies remain relevant, compete and win by applying the research knowledge.  She holds a Diploma of Applied Science (Nursing) and is a member of the Institute of Company Directors and Advisory Board Centre.



Bronwyn Harch FTSE, FQAAS, GAICD, AStat 


Professor Harch is the Deputy Vice-Chancellor (Research) and Vice-President (Research) of The University of Queensland. In this role, Professor Harch is responsible for enhancing the University’s performance and reputation in research, research training, and research collaboration with external stakeholders, nationally and internationally.

Before joining UQ in July 2018, Professor Harch was Executive Director of the Institute for Future Environments at Queensland University of Technology (QUT). She was also the establishment Research Director of the Australian Government Cooperative Research Centre on ‘Food Agility’ – a transdisciplinary partnership with industry aimed at growing the agrifood sector’s comparative advantage through digital transformation. Prior to joining QUT in 2014, Professor Harch worked for 18 years as a researcher and research strategist at the Commonwealth Scientific and Industrial Research Organisation (CSIRO).

Professor Harch’s own research has focused on the statistical design of landscape-scale sampling protocols and monitoring programs, as well as the statistical modelling of complex systems, particularly agri-environmental systems. She has developed transdisciplinary research; engagement and commercialisation strategies; and partnerships with state and federal governments and their agencies, Australian and multinational companies, and other research organisations. Professor Harch is a member of Innovation Science Australia (ISA), The Great Barrier Reef Independent Science Panel (ISP), the Australian Plant Phenomics Facility (APPF) Advisory Board, and the Plant Phenotyping and Imaging Research Centre (University of Saskatchewan) International Scientific Advisory Committee (ISAC).


Julian Clark PhD, FTSE, MAICD


Dr Clark has 40 years of international experience in governance and executive roles in technology transfer of biomedical and health innovations, both from academic and public research. 

Working from senior industry positions in Europe, Asia and North America, Dr Clark has commercialised many products and technologies including drugs, devices, diagnostics, processes and analytical instruments - virtually all having origins in academia. 

Dr Clark has most recently been Head of Business Development at the Walter and Eliza Hall Institute (WEHI) and was previously CEO of Faulding Pharmaceuticals (Australia), Pharmacia LKB Biotechnology (now GE and Pfizer, Sweden), Biochrom (UK) and the Cancer Therapeutics CRC (Australia). Amongst many products and technologies successfully brought to market, the drug Venatoclax is a stand-out from Dr Clark’s tenure at WEHI.  Through his consulting company, Dr Clark has assisted more than 100 organisations in Australia with their commercialisation strategies.

Dr Clark has extensive experience in working with more than 20 biomedical boards, recently including Cancer Trials Australia, BioGrid Australia, Nexpep, and Catalyst Therapeutics.  

Dr Clark has a PhD from the University of Glasgow and was a post-doctoral fellow at the Karolinska Institute in Stockholm.  A Doctor of the University (Uni SA) and Fellow of the Australia Academy of Technology and Engineering were awarded in recognition of Dr Clark’s significant contributions to technology transfer. 


Andrew Ritter BCom, CA, FGIA, FCIS  

Company Secretary

Mr Ritter was appointed as Company Secretary in October 2018. He has 20 years of international finance and governance experience, with 15 years as CFO and Company Secretary of publicly listed global technology organisations. He provides CFO and company secretarial consulting services for a start-up technology and ASX listed and unlisted public companies.

Mr Ritter is a Chartered Accountant, holds a Bachelor of Commerce degree, a Graduate Diploma of Applied Corporate Governance and is a Fellow of the Governance Institute of Australia and  the International Institute of Chartered Secretaries  and Administrators.